Clinical evaluation of a quantitative imaging biomarker supporting radiological assessment of hippocampal sclerosis
Published inClinical neuroradiology, vol. 33, no. 4, p. 1045-1053
Publication date2023-12
First online date2023-06-26
Abstract
Keywords
- Epilepsy
- HS
- MRI
- Morphometry
- Neuroradiology
- Quantitative Reporting
- Humans
- Epilepsy, Temporal Lobe / diagnostic imaging
- Epilepsy, Temporal Lobe / pathology
- Hippocampus / diagnostic imaging
- Hippocampus / pathology
- Hippocampal Sclerosis
- Sclerosis / diagnostic imaging
- Sclerosis / pathology
- Epilepsy / pathology
- Magnetic Resonance Imaging / methods
- Biomarkers
Affiliation entities
Research groups
Funding
- Swiss National Science Foundation - Network Diagnosis for Epilepsy [192749]
- Swiss National Science Foundation - Precision mapping of electrical brain network dynamics with application to epilepsy [209470]
- Swiss National Science Foundation - Predict and Monitor Epilepsy After a First Seizure: The Swiss-First Study [180365]
Citation (ISO format)
REBSAMEN, Michael et al. Clinical evaluation of a quantitative imaging biomarker supporting radiological assessment of hippocampal sclerosis. In: Clinical neuroradiology, 2023, vol. 33, n° 4, p. 1045–1053. doi: 10.1007/s00062-023-01308-9
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:176133
- DOI : 10.1007/s00062-023-01308-9
- PMID : 37358608
- PMCID : PMC10654177
Additional URL for this publicationhttps://link.springer.com/article/10.1007/s00062-023-01308-9
Journal ISSN1869-1439
